Smooth muscle cell (SMC) proliferation plays a critical role in several pathological states, including atherosclerosis and hypertension. Heparin suppresses SMC proliferation in vivo and in culture, but the mechanism of action is still poorly understood. In an accompanying article in this issue (Leto
Binding and internalization of heparin by vascular smooth muscle cells
โ Scribed by John J. Castellot Jr.; Kent Wong; Brian Herman; Richard L. Hoover; David F. Albertini; Thomas C. Wright; Benjamin L. Caleb; Morris J. Karnovsky
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 876 KB
- Volume
- 124
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The binding, internalization, and metabolism of 13H]-heparin by human umbilical vein endothelial cells (HUVEC) and human umbilical arterial smooth muscle cells (HUASMC) have been characterized using 5ize-exclusion HPLC. Incubation of HUVEC with ['HI-heparin demonstrated selective binding of high-mol
## Abstract Previous work from our laboratory has shown that heparin inhibits the proliferation of vascular smooth muscle cells in vivo and in vitro. The mechanism of action of this glycosaminoglycan is unknown. In this communication, we have examined the antiproliferative effect of heparin on smoo
Heparin suppresses the proliferation of vascular smooth muscle cells both in vivo and in vitro. The mechanism of action of the antiproliferative activity of heparin is not known. We have detected differences in the synthesis of specific proteins when vascular smooth muscle cells are exposed to hepar
Aberrant vascular smooth muscle cell (VSMC) hyperplasia is the hallmark of atherosclerosis and restenosis seen after vascular surgery. Heparin inhibits VSMC proliferation in animal models and in cell culture. To test our hypothesis that heparin mediates its antiproliferative effect by altering phosp